Compare Shigematsu Works Co., Ltd. with Similar Stocks
Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 2.92% over the last 5 years
- The company is Net-Debt Free
2
Poor long term growth as Net Sales has grown by an annual rate of 2.92% over the last 5 years
3
Flat results in Mar 26
4
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 5,947 Million (Micro Cap)
8.00
NA
0.00%
0.55
7.44%
0.63
Revenue and Profits:
Net Sales:
5,150 Million
(Quarterly Results - Mar 2026)
Net Profit:
486 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.14%
0%
-5.14%
6 Months
5.99%
0%
5.99%
1 Year
0.83%
0%
0.83%
2 Years
10.98%
0%
10.98%
3 Years
1.92%
0%
1.92%
4 Years
3.41%
0%
3.41%
5 Years
-15.69%
0%
-15.69%
Shigematsu Works Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.92%
EBIT Growth (5y)
0.16%
EBIT to Interest (avg)
30.21
Debt to EBITDA (avg)
1.65
Net Debt to Equity (avg)
0.42
Sales to Capital Employed (avg)
1.04
Tax Ratio
22.88%
Dividend Payout Ratio
15.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.42%
ROE (avg)
9.05%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.63
EV to EBIT
10.07
EV to EBITDA
5.40
EV to Capital Employed
0.75
EV to Sales
0.69
PEG Ratio
4.83
Dividend Yield
NA
ROCE (Latest)
7.49%
ROE (Latest)
7.78%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
5,150.30
4,421.70
16.48%
Operating Profit (PBDIT) excl Other Income
888.20
821.20
8.16%
Interest
30.20
15.10
100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
486.40
483.50
0.60%
Operating Profit Margin (Excl OI)
122.40%
135.30%
-1.29%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 16.48% vs 4.23% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 0.60% vs 23.75% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
15,593.50
14,112.60
10.49%
Operating Profit (PBDIT) excl Other Income
1,941.00
1,730.00
12.20%
Interest
183.10
40.90
347.68%
Exceptional Items
0.00
0.00
Consolidate Net Profit
702.20
780.60
-10.04%
Operating Profit Margin (Excl OI)
67.60%
75.80%
-0.82%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 10.49% vs 8.60% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is -10.04% vs 33.64% in Mar 2025
About Shigematsu Works Co., Ltd. 
Shigematsu Works Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






